These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 9744705)

  • 1. Nodular regenerative hyperplasia of the liver associated with a Factor V Leiden mutation.
    Lévy S; Diebold MD; Nguyen P; Lirzin P; Thiéfin G
    Eur J Gastroenterol Hepatol; 1998 Aug; 10(8):721. PubMed ID: 9744705
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cerebral venous thrombosis and factor V Leiden mutation].
    Meng Q; Pu C
    Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(1):47-9. PubMed ID: 11953127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the factor V Leiden mutation on infectious disease susceptibility and outcome: a population-based study.
    Benfield TL; Dahl M; Nordestgaard BG; Tybjaerg-Hansen A
    J Infect Dis; 2005 Nov; 192(10):1851-7. PubMed ID: 16235188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
    Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
    J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myointimal hyperplasia of mesenteric veins secondary to heterozygous factor V Leiden mutation.
    De Hertogh G; Van Eyken P; Stessens L; Caenepeel P; Geoboes K
    Histopathology; 2005 Sep; 47(3):322-4. PubMed ID: 16115236
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of the factor V Leiden mutation on the clinical expression of severe hemophilia A.
    Lee DH; Walker IR; Teitel J; Poon MC; Ritchie B; Akabutu J; Sinclair GD; Pai M; Wu JW; Reddy S; Carter C; Growe G; Lillicrap D; Lam M; Blajchman MA
    Thromb Haemost; 2000 Mar; 83(3):387-91. PubMed ID: 10744141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of factor V mutation on the risk for occlusion in patients undergoing peripheral vascular reconstructions.
    Sampram ES; Lindblad B
    Eur J Vasc Endovasc Surg; 2001 Aug; 22(2):134-8. PubMed ID: 11472046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor V Leiden mutation in postthrombotic and non-postthrombotic venous ulcers.
    Hafner J; Kühne A; Schär B; Bombeli T; Hauser M; Lüthi R; Hänseler E
    Arch Dermatol; 2001 May; 137(5):599-603. PubMed ID: 11346337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budd-Chiari syndrome associated with factor V leiden mutation: a report of 6 patients.
    Hoffman R; Nimer A; Lanir N; Brenner B; Baruch Y
    Liver Transpl Surg; 1999 Mar; 5(2):96-100. PubMed ID: 10071347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
    Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
    Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis.
    van Dunné FM; Doggen CJ; Heemskerk M; Rosendaal FR; Helmerhorst FM
    Hum Reprod; 2005 Mar; 20(3):802-6. PubMed ID: 15618258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of mortality and the factor V Leiden mutation in a population-based cohort.
    Heijmans BT; Westendorp RG; Knook DL; Kluft C; Slagboom PE
    Thromb Haemost; 1998 Oct; 80(4):607-9. PubMed ID: 9798979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
    Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of factor V Leiden mutations on prognosis in patients with acute myocardial infarction].
    Baykan M; Celik S; Uçar F; Kaplan S; Ovali E; Erdöl C
    Anadolu Kardiyol Derg; 2001 Dec; 1(4):242-5; AXIV. PubMed ID: 12101832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
    González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V Leiden mutation and type 1 diabetes mellitus.
    Demirer AN; Alikasifoglu M; Tuncbilek E; Karakus S; Erbas T
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):70-4. PubMed ID: 18180619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee.
    Björkman A; Burtscher IM; Svensson PJ; Hillarp A; Besjakov J; Benoni G
    Arch Orthop Trauma Surg; 2005 Feb; 125(1):51-5. PubMed ID: 15723247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Leiden mutation in one family of Chinese origin.
    Wu J; Gu J; Xu J; Wang J; Sun Z; Smirnov MD; Morrissey JH; Esmon N
    Chin Med J (Engl); 2001 Apr; 114(4):379-81. PubMed ID: 11780458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation.
    Pablos JL; Caliz RA; Carreira PE; Atsumi T; Serrano L; Amengual O; Santiago B; Khamashta MA; Hughes GR; Gomez-Reino JJ
    J Rheumatol; 1999 Mar; 26(3):588-90. PubMed ID: 10090167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Third trimester nonrecurrent fetal loss is associated with factor V Leiden and prothrombin gene mutations.
    Karateke A; Haliloglu B; Gurbuz A
    J Matern Fetal Neonatal Med; 2005 Nov; 18(5):299-304. PubMed ID: 16390788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.